Viewing Study NCT04218734


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-02-22 @ 9:36 AM
Study NCT ID: NCT04218734
Status: COMPLETED
Last Update Posted: 2021-06-28
First Post: 2020-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DBPR108 View
None Dipeptidyl peptidase-4 (DPP4) inhibitors View
None metformin hydrochloride View